4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-003563
Chief Executive Officer gave up 5,219 shares (to pay taxes)
- Chief Executive Officer acquired 1,655 shares (other)
- Chief Executive Officer acquired 19,767 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Chief Executive Officer | 2022-10-31 | Other acquisition | +1,655 | $3.27 | $5,416 | 163,441 | D |
| Quart Barry D Chief Executive Officer | 2023-01-13 | Option exercise | +3,645 | 167,086 | D | ||
| Quart Barry D Chief Executive Officer | 2023-01-13 | Option exercise | +16,122 | 183,208 | D | ||
| Quart Barry D Chief Executive Officer | 2023-01-13 | Shares withheld for taxes | −5,219 | $3.17 | $16,544 | 177,989 | D |
| Derivatives | |||||||
| Quart Barry D Chief Executive Officer | 2023-01-13 | Option exercise · Restricted Stock Units | −3,645 | 25,521 | D | ||
| Quart Barry D Chief Executive Officer | 2023-01-13 | Option exercise · Restricted Stock Units | −16,122 | 114,807 | D | ||
Loading xslF345X03/doc4.xml…